Published in Nature on March 12, 1981
Overcoming reprogramming resistance of Fanconi anemia cells. Blood (2012) 2.07
Loss of Rb proteins causes genomic instability in the absence of mitogenic signaling. Genes Dev (2010) 1.88
Cellular and molecular consequences of defective Fanconi anemia proteins in replication-coupled DNA repair: mechanistic insights. Mutat Res (2009) 1.80
Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex. Mol Cell Biol (1999) 1.73
Fanconi anaemia. J Med Genet (2003) 1.70
TNF-alpha induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells. J Clin Invest (2007) 1.53
Cytoprotective effect of honey against chromosomal breakage in fanconi anemia patients in vitro. Indian J Hum Genet (2011) 1.38
Oxidative stress in Fanconi anemia hematopoiesis and disease progression. Antioxid Redox Signal (2008) 1.33
Fancd2-/- mice have hematopoietic defects that can be partially corrected by resveratrol. Blood (2010) 1.29
Defective mitochondrial peroxiredoxin-3 results in sensitivity to oxidative stress in Fanconi anemia. J Cell Biol (2006) 1.21
Pathways for repairing and tolerating the spectrum of oxidative DNA lesions. Cancer Lett (2012) 1.20
Fanconi anemia proteins and endogenous stresses. Mutat Res (2009) 1.11
Lentiviral-mediated genetic correction of hematopoietic and mesenchymal progenitor cells from Fanconi anemia patients. Mol Ther (2009) 1.07
Oxidative stress-specific interaction between FANCD2 and FOXO3a. Blood (2009) 1.04
Fanconi anemia mutation causes cellular susceptibility to ambient oxygen. Am J Hum Genet (1988) 1.03
Endogenous blockage and delay of the chromosome cycle despite normal recruitment and growth phase explain poor proliferation and frequent edomitosis in Fanconi anemia cells. Am J Hum Genet (1985) 1.01
Fanconi anemia: young patients at high risk for squamous cell carcinoma. Mol Cell Pediatr (2014) 1.00
Diagnostic Overlap between Fanconi Anemia and the Cohesinopathies: Roberts Syndrome and Warsaw Breakage Syndrome. Anemia (2010) 0.95
Oxidative stress and mitochondrial dysfunction across broad-ranging pathologies: toward mitochondria-targeted clinical strategies. Oxid Med Cell Longev (2014) 0.95
In vivo repopulation ability of genetically corrected bone marrow cells from Fanconi anemia patients. Proc Natl Acad Sci U S A (2006) 0.94
Biomarkers and mechanisms of FANCD2 function. J Biomed Biotechnol (2008) 0.89
DNA repair dependent NAD+ metabolism is impaired in cells from patients with Fanconi's anemia. EMBO J (1983) 0.89
Disrupted Signaling through the Fanconi Anemia Pathway Leads to Dysfunctional Hematopoietic Stem Cell Biology: Underlying Mechanisms and Potential Therapeutic Strategies. Anemia (2012) 0.88
A Rad50-dependent pathway of DNA repair is deficient in Fanconi anemia fibroblasts. Nucleic Acids Res (2004) 0.86
Oxidative stress-related mechanisms are associated with xenobiotics exerting excess toxicity to Fanconi anemia cells. Environ Health Perspect (2003) 0.85
FANCD2-deficient human fibroblasts are hypersensitive to ionising radiation at oxygen concentrations of 0% and 3% but not under normoxic conditions. Int J Radiat Biol (2009) 0.84
Improvement of genetic stability in lymphocytes from Fanconi anemia patients through the combined effect of α-lipoic acid and N-acetylcysteine. Orphanet J Rare Dis (2012) 0.83
Genetic instability syndromes with progeroid features. Z Gerontol Geriatr (2007) 0.83
Evaluation of resveratrol and N-acetylcysteine for cancer chemoprevention in a Fanconi anemia murine model. Pediatr Blood Cancer (2013) 0.82
Damaged mitochondria in Fanconi anemia - an isolated event or a general phenomenon? Oncoscience (2014) 0.82
Damaged mitochondria and overproduction of ROS in Fanconi anemia cells. Rare Dis (2013) 0.82
Fanconi anemia proteins and their interacting partners: a molecular puzzle. Anemia (2012) 0.82
Cells Deficient in the Fanconi Anemia Protein FANCD2 are Hypersensitive to the Cytotoxicity and DNA Damage Induced by Coffee and Caffeic Acid. Toxins (Basel) (2016) 0.81
Induced pluripotent stem cells as a tool for gaining new insights into Fanconi anemia. Cell Cycle (2012) 0.80
Fanconi Anemia: A DNA repair disorder characterized by accelerated decline of the hematopoietic stem cell compartment and other features of aging. Ageing Res Rev (2016) 0.80
Clastogenic factors as potential biomarkers of increased superoxide production. Biomark Insights (2007) 0.79
Oxidative stress-associated protein tyrosine kinases and phosphatases in Fanconi anemia. Antioxid Redox Signal (2014) 0.76
Concomitant inactivation of foxo3a and fancc or fancd2 reveals a two-tier protection from oxidative stress-induced hydrocephalus. Antioxid Redox Signal (2014) 0.76
TGF-β: a master regulator of the bone marrow failure puzzle in Fanconi anemia. Stem Cell Investig (2016) 0.75
Impaired mitophagy in Fanconi anemia is dependent on mitochondrial fission. Oncotarget (2016) 0.75
Increased red cell distribution width in Fanconi anemia: a novel marker of stress erythropoiesis. Orphanet J Rare Dis (2016) 0.75
A never-ending story: the steadily growing family of the FA and FA-like genes. Genet Mol Biol (2017) 0.75
The Cowden syndrome: a clinical and genetic study in 21 patients. Clin Genet (1986) 2.78
Cost effectiveness of shortening screening interval or extending age range of NHS breast screening programme: computer simulation study. BMJ (1998) 2.61
Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening. Int J Epidemiol (1998) 2.49
Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA. Nat Genet (1996) 2.36
Extra incidence caused by mammographic screening. Lancet (1994) 2.19
The Fanconi anaemia group G gene FANCG is identical with XRCC9. Nat Genet (1998) 1.99
Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance. Eur J Hum Genet (1997) 1.89
Classification of Fanconi anemia patients by complementation analysis: evidence for a fifth genetic subtype. Blood (1995) 1.82
Spontaneous functional correction of homozygous fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism. Nat Genet (1999) 1.81
Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity. Pharmacol Ther (1990) 1.73
Transformation in Bacillus subtilis. Fate of newly introduced transforming DNA. Mol Gen Genet (1973) 1.68
Inherited susceptibility to bleomycin-induced chromatid breaks in cultured peripheral blood lymphocytes. J Natl Cancer Inst (1999) 1.68
The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. Nat Genet (2000) 1.64
Evidence for at least eight Fanconi anemia genes. Am J Hum Genet (1997) 1.61
High frequency of large intragenic deletions in the Fanconi anemia group A gene. Am J Hum Genet (1999) 1.60
Mice with a targeted disruption of the Fanconi anemia homolog Fanca. Hum Mol Genet (2000) 1.56
Interactions between exogenous deoxyribonucleic acid and membrane vesicles isolated from competent and noncompetent Bacillus subtilis. J Bacteriol (1975) 1.55
Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation. J Clin Pathol (1998) 1.54
The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes. Genomics (1989) 1.54
Linkage disequilibrium patterns vary with chromosomal location: a case study from the von Willebrand factor region. Am J Hum Genet (1994) 1.52
Isolation of a cDNA representing the Fanconi anemia complementation group E gene. Am J Hum Genet (2000) 1.51
The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum Mol Genet (2000) 1.48
Visual acuity in 183 cases of X-chromosomal retinoschisis. Can J Ophthalmol (1973) 1.46
Cell culture models for oxidative stress: superoxide and hydrogen peroxide versus normobaric hyperoxia. Mutat Res (1992) 1.43
Microcell mediated chromosome transfer maps the Fanconi anaemia group D gene to chromosome 3p. Nat Genet (1995) 1.43
Genes amplified and overexpressed in human multidrug-resistant cell lines. Cancer Res (1988) 1.42
Statistical analysis of the seasonal variation in the twinning rate. Twin Res (1999) 1.41
Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line. Cancer Res (1990) 1.39
Reduction in breast cancer mortality due to the introduction of mass screening in The Netherlands: comparison with the United Kingdom. J Med Screen (1999) 1.39
Different nuclease activities in competent and noncompetent Bacillus subtilis. J Bacteriol (1975) 1.37
A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA. Proc Natl Acad Sci U S A (1999) 1.32
The fanconi anemia pathway requires FAA phosphorylation and FAA/FAC nuclear accumulation. Proc Natl Acad Sci U S A (1998) 1.30
Integrated human papillomavirus type 16 and loss of heterozygosity at 11q22 and 18q21 in an oral carcinoma and its derivative cell line. Cancer Res (1995) 1.29
Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group. Blood (2000) 1.29
Interactions between exogenous deoxyribonucleic acid and membrane vesicles isolated from Bacillus subtilis 168. J Bacteriol (1974) 1.26
Increased cytosolic pH in multidrug-resistant human lung tumor cells: effect of verapamil. J Natl Cancer Inst (1989) 1.23
Gene mapping in isolated populations: new roles for old friends? Hum Hered (2000) 1.23
Correlation of multidrug resistance with decreased drug accumulation, altered subcellular drug distribution, and increased P-glycoprotein expression in cultured SW-1573 human lung tumor cells. Cancer Res (1989) 1.22
Immortalization of four new Fanconi anemia fibroblast cell lines by an improved procedure. Somat Cell Mol Genet (1996) 1.20
Linkage studies in autosomal dominant facioscapulohumeral muscular dystrophy. J Neurol Sci (1984) 1.19
Restriction and modification in Bacillus subtilis. Induction of a modifying activity in Bacillus subtilis 168. Mol Gen Genet (1974) 1.17
Evidence of duplication of the human salivary amylase gene. Hum Genet (1982) 1.16
Linkage relationships and gene order around the locus for X-linked retinoschisis. Am J Hum Genet (1988) 1.15
Protease-sensitive transfection of Bacillus subtilis with bacteriophage GA-1 DNA: a probable case of heterologous transfection. J Virol (1974) 1.14
Rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration. Ann Neurol (1992) 1.11
Fanconi anemia genes act to suppress a cross-linker-inducible p53-independent apoptosis pathway in lymphoblastoid cell lines. Blood (1996) 1.11
Mutations induced by X-rays at the HPRT locus in cultured Chinese hamster cells are mostly large deletions. Mutat Res (1985) 1.09
Transfection of Bacillus subtilis with bacteriophage H1 DNA: fate of transfecting DNA and transfection enhancement in B. subtilis uur+ and uur- strains. Mol Gen Genet (1974) 1.09
Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels. Cancer (1987) 1.08
Localization of the gene for rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration to chromosome 17q21. Hum Mol Genet (1996) 1.07
Molecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South Africa. Proc Natl Acad Sci U S A (2001) 1.07
Fanconi anaemia in Italy: high prevalence of complementation group A in two geographic clusters. Hum Genet (1996) 1.06
Genetic mapping of 12 marker loci in the Xp22.3-p21.2 region. Hum Genet (1991) 1.06
Comparative genomic hybridization: a new tool in cancer pathology. Hum Pathol (1996) 1.05
Subtyping analysis of Fanconi anemia by immunoblotting and retroviral gene transfer. Mol Med (1998) 1.03
Twinning and legitimacy. Hereditas (1967) 1.03
Stimulation of the development of competence by culture fluids in Bacillus subtilis transformation. Biochim Biophys Acta (1972) 1.02
The Fanconi anemia group E gene, FANCE, maps to chromosome 6p. Am J Hum Genet (1999) 1.02
Nucleotide sequence comparison of five human pepsinogen A (PGA) genes: evolution of the PGA multigene family. Genomics (1989) 1.01
Centromeric breakage as a major cause of cytogenetic abnormalities in oral squamous cell carcinoma. Genes Chromosomes Cancer (1996) 1.00
Statistical analysis of the seasonal variation in demographic data. Hum Biol (2000) 1.00
Twinning in relation to the marital status of the mother. Acta Genet Stat Med (1967) 0.99
Serum cholesterol and triglyceride concentrations of Finns and Finnish Lapps. I. Basic data. Acta Med Scand (1975) 0.99
Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A. Am J Hum Genet (2000) 0.98
Evolution of the human alpha-amylase multigene family through unequal, homologous, and inter- and intrachromosomal crossovers. Genomics (1990) 0.98
Cost-effectiveness of mammographic screening in Australia. Aust J Public Health (1993) 0.97
Mutagenicity of metabolic oxygen radicals in mammalian cell cultures. Carcinogenesis (1994) 0.97
Variation in gene copy number and polymorphism of the human salivary amylase isoenzyme system in Caucasians. Hum Genet (1992) 0.96
alpha1-antitrypsin: common subtypes of Pi M. Hum Hered (1976) 0.96
Respiratory failure and stimulation of glycolysis in Chinese hamster ovary cells exposed to normobaric hyperoxia. J Biol Chem (1990) 0.96
Letter: Superoxide dismutase in Down syndrome. Lancet (1975) 0.96
Inability of chemically generated singlet oxygen to break the DNA backbone. Free Radic Res Commun (1985) 0.96
Reliable classification of six Pi M subtypes by separator isoelectric focusing. Hum Hered (1978) 0.96
Drug sensitivity spectra in Fanconi anemia lymphoblastoid cell lines of defined complementation groups. Mutat Res (1999) 0.95
Genetic polymorphisms in Finno-Ugrian populations. Finns, Lapps and Maris. Isr J Med Sci (1974) 0.94
Localization of the Aland Island eye disease locus to the pericentromeric region of the X chromosome by linkage analysis. Am J Hum Genet (1991) 0.94
Induction of prophage SPO2 in Bacillus subtilis by 6-(para)-hydroxyphenylazouracil. J Virol (1974) 0.94
Genetics of urinary pepsinogen: a new hypothesis. Hum Genet (1984) 0.94
Mutational specificity of oxidative DNA damage. Mutat Res (1993) 0.93